Skip to Main Content

Paper Details

MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
Neuro Oncol
143
2016
3' untranslated regions, CD4, CD4+, CD4+ or CD8+ T cells, CD8+, CONCLUSIONS, CONCLUSIONS MiR-138, CTLA-4, Forkhead box protein 3, FoxP3, FoxP3+, FoxP3+ regulatory T cells, GL261 glioma, GL261 gliomas, MiR, MiR-138, MicroRNAs, PD-1, T cells, cytotoxic T-lymphocyte-associated molecule 4, gene transcripts, glioma, glioma cells, human, human CD4+ T cells, intratumoral FoxP3+ regulatory T cells, luciferase, miR, miR-138, miRNAs, mice, programmed cell death 1, transfected human CD4+ T cells, tumor
Author NameAffiliation
Jun WeiThe University of Texas MD Anderson Cancer Center, S.Z.) Center for RNA Interference and Non-Coding RNAs, Qilu Hospital of Shandong University
Ling-Yuan KongThe University of Texas MD Anderson Cancer Center, S.Z.) Center for RNA Interference and Non-Coding RNAs, Qilu Hospital of Shandong University
Qingyi WeiThe University of Texas MD Anderson Cancer Center, S.Z.) Center for RNA Interference and Non-Coding RNAs, Qilu Hospital of Shandong University
Cristina IvanThe University of Texas MD Anderson Cancer Center, S.Z.) Center for RNA Interference and Non-Coding RNAs, Qilu Hospital of Shandong University
Gregory N FullerThe University of Texas MD Anderson Cancer Center, S.Z.) Center for RNA Interference and Non-Coding RNAs, Qilu Hospital of Shandong University
Gregory N FullerThe University of Texas MD Anderson Cancer Center, S.Z.) Center for RNA Interference and Non-Coding RNAs, Qilu Hospital of Shandong University
Amy B HeimbergerThe University of Texas MD Anderson Cancer Center, S.Z.) Center for RNA Interference and Non-Coding RNAs, Qilu Hospital of Shandong University
  • 1 - 7

Datasets

Release 1.2